KS
Katherine Stueland
Chief Executive Officer

Katherine Stueland insider trades: GeneDx Holdings (WGS) stock buys and sales

Chief Executive Officer, GeneDx Holdings Last trade Sep 16, 2026 96 Form 4 filings
$7.8M
Sold, last 12 months
9 sales
$0
Bought, last 12 months
0 buys
85
Open-market trades
since 2017
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Katherine reports to the SEC

Open-market buys and sales

85 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 16, 2026WGS↓ Sell$1.0M
Sep 9, 2026WGS↓ Sell$311K
Jun 16, 2026WGS↓ Sell$638K
Jun 9, 2026WGS↓ Sell$196K
Mar 16, 2026WGS↓ Sell$1.3M
Mar 4, 2026WGS↓ Sell$2.0M
Jan 29, 2026WGS↓ Sell$155K
Dec 16, 2025WGS↓ Sell$1.6M
Dec 9, 2025WGS↓ Sell$580K
Oct 29, 2025WGS↓ Sell$295K
Sep 30, 2025WGS↓ Sell$1.4M
Sep 16, 2025WGS↓ Sell$1.3M
Sep 9, 2025WGS↓ Sell$468K
Jul 29, 2025WGS↓ Sell$227K
Jul 9, 2025WGS↓ Sell$299K
Jul 1, 2025WGS↓ Sell$878K
Jun 16, 2025WGS↓ Sell$680K
Jun 9, 2025WGS↓ Sell$264K
Apr 29, 2025WGS↓ Sell$244K
Apr 9, 2025WGS↓ Sell$4.2M
Mar 26, 2025WGS↓ Sell$4.5M
Mar 17, 2025WGS↓ Sell$1.1M
Mar 10, 2025WGS↓ Sell$259K
Jan 29, 2025WGS↓ Sell$130K
Jan 7, 2025WGS↓ Sell$4.9M
Jan 2, 2025WGS↓ Sell$1.4M
Dec 16, 2024WGS↓ Sell$806K
Dec 9, 2024WGS↓ Sell$280K
Nov 18, 2024WGS↓ Sell$3.2M
Oct 29, 2024WGS↓ Sell$143K
Sep 16, 2024WGS↓ Sell$395K
Sep 9, 2024WGS↓ Sell$121K
Jul 29, 2024WGS↓ Sell$72K
Jun 17, 2024WGS↓ Sell$218K
Jun 10, 2024WGS↓ Sell$66K
Apr 29, 2024WGS↓ Sell$70K
Mar 18, 2024WGS↓ Sell$91K
Mar 12, 2024WGS↓ Sell$24K
Dec 18, 2023WGS↓ Sell$25K
Dec 11, 2023WGS↓ Sell$6K
Sep 18, 2023WGS↓ Sell$45K
Sep 11, 2023WGS↓ Sell$12K
Jun 20, 2023WGS↓ Sell$51K
Jun 12, 2023WGS↓ Sell$17K
May 16, 2023WGS↓ Sell$56K
Mar 10, 2023WGS↓ Sell$33K
Nov 28, 2022SMFR↑ Buy$100K
Jun 14, 2021NVTA↓ Sell10b5-1$643K
Apr 14, 2021NVTA↓ Sell10b5-1$793K
Mar 15, 2021NVTA↓ Sell$534K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other WGS insiders

Open-market trades in the last 12 months

About Katherine Stueland's insider trades

Katherine Stueland is Chief Executive Officer at GeneDx Holdings (WGS). Since Feb 15, 2017, Katherine has reported 1 open-market purchase worth $100K and 84 sales worth $42.8M on SEC Form 4. In the last 12 months: 9 sales ($7.8M).

7 sales (5% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (40 filings), grants and awards (14 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WGS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.